组织和溶性LOX-1与人类腹腔大动脉动脉瘤的关联

Anja Hofmann1, Yazan Khorzom1, Anna Klimova2

  • 1Division of Vascular and Endovascular Surgery, Department of Visceral, Thoracic and Vascular Surgery Faculty of Medicine andUniversity Hospital Carl Gustav Carus, Technische Universität Dresden Dresden Germany.

概括

在患有腹腔大动脉动脉瘤 (AAA) 的患者中,可溶性莱克样氧化低密度脂蛋白受体-1 (sLOX-1) 水平较高,但无法预测AAA大小或破裂风险. 大动脉LOX-1表达在AAA中增加,可能抵消破裂.